Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Net income as a percentage of revenue
3Y CAGR
-61.3%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 98.54% | +212.4% |
| 2024 | -87.63% | +8.8% |
| 2023 | -96.11% | -105.7% |
| 2022 | 1698.54% | +571.1% |
| 2021 | -360.55% | +6.8% |
| 2020 | -386.90% | -20.1% |
| 2019 | -322.08% | +9.8% |
| 2018 | -357.01% | +80.8% |
| 2017 | -1854.97% | -373.3% |
| 2016 | -391.94% | - |